1. Home
  2. DOMO vs DCTH Comparison

DOMO vs DCTH Comparison

Compare DOMO & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$8.70

Market Cap

477.0M

Sector

Technology

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.24

Market Cap

350.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
DCTH
Founded
2010
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
477.0M
350.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
DOMO
DCTH
Price
$8.70
$10.24
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$14.38
$22.60
AVG Volume (30 Days)
1.0M
596.1K
Earning Date
12-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$318,002,000.00
$79,603,000.00
Revenue This Year
$2.28
$131.97
Revenue Next Year
$2.45
$38.84
P/E Ratio
N/A
$291.69
Revenue Growth
N/A
251.54
52 Week Low
$6.01
$8.12
52 Week High
$18.49
$18.23

Technical Indicators

Market Signals
Indicator
DOMO
DCTH
Relative Strength Index (RSI) 33.42 57.97
Support Level $8.55 $9.84
Resistance Level $9.22 $10.44
Average True Range (ATR) 0.53 0.43
MACD 0.06 0.03
Stochastic Oscillator 9.34 55.56

Price Performance

Historical Comparison
DOMO
DCTH

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: